However, significant barriers stand in the way of realising this promise on a worldwide scale, from manufacturing costs and ...

A century-in-the-making pandemic was on its way and we, in the live marketing industry – like everyone – were pretty much ...

It is incumbent not only on people to have the willingness to learn, but also on pharmaceutical and scientific industries to ...

Shares in 23andMe are currently trading at around $3.40, giving it a valuation of just under $82 million. The company went ...

The alliance will pair EVERSANA's NAVLIN platform, which provides data and information on global pricing and market access, ...

The European Medicines Agency (EMA) has joined the hordes of users abandoning Elon Musk's X.com (formerly Twitter) and will ...

As recent advances in small molecules, ADCs, cell, and gene therapies poise novel precision therapies from the bench to the ...